These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 38607003)

  • 1. Hippo Signaling at the Hallmarks of Cancer and Drug Resistance.
    Kumar R; Hong W
    Cells; 2024 Mar; 13(7):. PubMed ID: 38607003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional output of the Salvador/warts/hippo pathway is controlled in distinct fashions in Drosophila melanogaster and mammalian cell lines.
    Zhang X; Milton CC; Humbert PO; Harvey KF
    Cancer Res; 2009 Aug; 69(15):6033-41. PubMed ID: 19584286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Hippo pathway integrates PI3K-Akt signals with mechanical and polarity cues to control tissue growth.
    Borreguero-Muñoz N; Fletcher GC; Aguilar-Aragon M; Elbediwy A; Vincent-Mistiaen ZI; Thompson BJ
    PLoS Biol; 2019 Oct; 17(10):e3000509. PubMed ID: 31613895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifaceted regulation and functions of YAP/TAZ in tumors (Review).
    Liu H; Du S; Lei T; Wang H; He X; Tong R; Wang Y
    Oncol Rep; 2018 Jul; 40(1):16-28. PubMed ID: 29749524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway.
    Zhang J; Ji JY; Yu M; Overholtzer M; Smolen GA; Wang R; Brugge JS; Dyson NJ; Haber DA
    Nat Cell Biol; 2009 Dec; 11(12):1444-50. PubMed ID: 19935651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YAP/TAZ for cancer therapy: opportunities and challenges (review).
    Guo L; Teng L
    Int J Oncol; 2015 Apr; 46(4):1444-52. PubMed ID: 25652178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Hippo signaling pathway: from multiple signals to the hallmarks of cancers.
    Zhu N; Yang R; Wang X; Yuan L; Li X; Wei F; Zhang L
    Acta Biochim Biophys Sin (Shanghai); 2023 Mar; 55(6):904-913. PubMed ID: 36942989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Hippo Pathway in Cancer Stem Cell Biology.
    Park JH; Shin JE; Park HW
    Mol Cells; 2018 Feb; 41(2):83-92. PubMed ID: 29429151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDK7 regulates organ size and tumor growth by safeguarding the Hippo pathway effector Yki/Yap/Taz in the nucleus.
    Cho YS; Li S; Wang X; Zhu J; Zhuo S; Han Y; Yue T; Yang Y; Jiang J
    Genes Dev; 2020 Jan; 34(1-2):53-71. PubMed ID: 31857346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WWC proteins mediate LATS1/2 activation by Hippo kinases and imply a tumor suppression strategy.
    Qi S; Zhu Y; Liu X; Li P; Wang Y; Zeng Y; Yu A; Wang Y; Sha Z; Zhong Z; Zhu R; Yuan H; Ye D; Huang S; Ling C; Xu Y; Zhou D; Zhang L; Yu FX
    Mol Cell; 2022 May; 82(10):1850-1864.e7. PubMed ID: 35429439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Emerging Role of the Hippo Pathway in Lung Cancers: Clinical Implications.
    Teoh SL; Das S
    Curr Drug Targets; 2017 Nov; 18(16):1880-1892. PubMed ID: 27628948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-hippo kinases: indispensable roles in YAP/TAZ signaling and implications in cancer therapy.
    Zhu J; Wu T; Lin Q
    Mol Biol Rep; 2023 May; 50(5):4565-4578. PubMed ID: 36877351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reciprocal regulation of YAP/TAZ by the Hippo pathway and the Small GTPase pathway.
    Jang JW; Kim MK; Bae SC
    Small GTPases; 2020 Jul; 11(4):280-288. PubMed ID: 29457552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complex roles of Hippo-YAP/TAZ signaling in hepatocellular carcinoma.
    Shi H; Zou Y; Zhong W; Li Z; Wang X; Yin Y; Li D; Liu Y; Li M
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):15311-15322. PubMed ID: 37608027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central role of Yes-associated protein and WW-domain-containing transcriptional co-activator with PDZ-binding motif in pancreatic cancer development.
    Rozengurt E; Eibl G
    World J Gastroenterol; 2019 Apr; 25(15):1797-1816. PubMed ID: 31057295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Hippo signaling pathway provides novel anti-cancer drug targets.
    Bae JS; Kim SM; Lee H
    Oncotarget; 2017 Feb; 8(9):16084-16098. PubMed ID: 28035075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease implications of the Hippo/YAP pathway.
    Plouffe SW; Hong AW; Guan KL
    Trends Mol Med; 2015 Apr; 21(4):212-22. PubMed ID: 25702974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hippo signaling pathway in development and cancer.
    Pan D
    Dev Cell; 2010 Oct; 19(4):491-505. PubMed ID: 20951342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent WWTR1 S89W mutations and Hippo pathway deregulation in clear cell carcinomas of the cervix.
    Kim SH; Basili T; Dopeso H; Da Cruz Paula A; Bi R; Issa Bhaloo S; Pareja F; Li Q; da Silva EM; Zhu Y; Hoang T; Selenica P; Murali R; Chan E; Wu M; Derakhshan F; Maroldi A; Hanlon E; Ferreira CG; Lapa E Silva JR; Abu-Rustum NR; Zamarin D; Chandarlapaty S; Matrai C; Yoon JY; Reis-Filho JS; Park KJ; Weigelt B
    J Pathol; 2022 Aug; 257(5):635-649. PubMed ID: 35411948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version.
    Zhao B; Li L; Lei Q; Guan KL
    Genes Dev; 2010 May; 24(9):862-74. PubMed ID: 20439427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.